Fragmos Chain has initiated a collective trial involving over 10 leading investment banks, collectively representing a 30% market share among broker-dealers. The focus of this trial is the transformation of OTC derivatives processing.
During a meeting sponsored by a major Investment Bank, these banks have acknowledged the increased efficiency, reduced risks, and substantial cost savings offered by our solution. In particular, several of them have shared their experience with one another, including signed agreements, successful trial runs, and integration with their systems.
The trial, enabling collaborative utilization of our solution, will serve as a stepping stone toward full-scale implementation. Moreover, beyond the trial, these banks are forging a community that will shape the future of OTC derivatives processing and welcome additional participants.
We are confident that this initiative will yield significant benefits for the Industry.
